Leslie O'Dell, Aeire (C), Alcon (C), Allergan (C), Bausch Health (C), Eye Eco (C), Eyevance (C), Glaukos (C), JNJ vision (C), Kala (C), Novartis (C), Shire (C), Sight Sciences (C), Sun (C), Takeda (C);
Clare Halleran, Allergan (C), Shire Canada (C);
Scott Schwartz, Alcon (F), Bausch Health (F);
Scott Hauswirth, Alcon (C), Allergan (C), Avedro (C), Biotissue/Tissue Tech (C), Dompe (C), EyePoint Pharma (C), EyeVance (C), Glaukos (C), Horizon (C), Hovione (C), JNJ vision (C), Kala (C), Novartis (C), NuSight Medical (C), Ocular Therapeutix (C), Science based health (C), Sight Sciences (C), Sun (C), Takeda (C), TearRestore (C), Tear Solutions (C);
Jonathan Andrews, None;
Jennifer Harthan, Allergan (R), Contamac (F), Essilor (R), Essilor (C), Kala (F), Metro (F), Metro Optics (R), Metro Optics (C), SynergEyes (R), Takeda (R), Tangible Science (F);
justin kwan, None;
Jacob Lang, Allergan (C), Horizon (C), Novartis (C), Ocular Therapeutix (C), Sun (C);
katherine mastrota, Ocusoft (I), Science based Health (C), Sun (C), Tear Lab (I);
Tracy Doll, Allergan (C), Bausch Health (C), Novartis (C), Sun (C), Tissue Tech (C);
Milton Hom, Allergan (C), Bausch Health (C), Eyenovia (C), Eyevance (C), Hovione (C), Kala (C), Novartis (C), Shire (C), Sydnexis (C), Tarsus (C)